Treo Ventures

Treo Ventures is a healthcare investment firm backing medical-device and digital-health companies in the United States and Europe. It invests in medical technology companies addressing large unmet clinical needs, with a portfolio spanning neuromodulation, cardiovascular and neurovascular care, respiratory medicine, ophthalmology, orthopedics and metabolic health. The firm operates from a presence in the United States, Ireland and Europe.

Investment activity covers both early proof-of-concept and later-stage companies, the latter typically at points where clinical evidence supports regulatory progress or preparation for commercialisation. Alongside its direct investments, Treo Ventures runs NuXcel, a medical device accelerator that generates investment opportunities for the firm.

The team is composed of founders, operators, company builders and investors, drawing on experience across healthcare investing and operating roles. The firm describes a hands-on approach, working alongside portfolio company leaders on product development, clinical and regulatory planning, and commercialisation, and concentrating its involvement where its experience and relationships can provide practical support to a company and its technology.